Suppr超能文献

亚硝基胍化合物的微粒体介导的脱亚硝化作用。

Microsomally-mediated denitrosation of nitrosoguanidinium compounds.

作者信息

Jensen D E, Stelman G J, Williams A W

机构信息

Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA 19140.

出版信息

Carcinogenesis. 1990 Jul;11(7):1075-82. doi: 10.1093/carcin/11.7.1075.

Abstract

A major metabolic fate of 1-methyl-2-nitro-1-nitrosoguanidine (MNNG) and nitrosocimetidine (NC) in rodents is denitrosation to generate the unmodified, parent guanidinium compound. MNNG is a potent, locally-acting carcinogen. NC is the nitrosated derivative of cimetidine, an important clinical drug administered orally for the treatment of stomach ulcers. Contrary to expectations based on the results of various short-term in vitro tests for carcinogenic potential, NC is not a carcinogen when administered to rats or mice. Rat liver microsomal enzymes have been found to be capable of catalyzing the denitrosation of MNNG, NC and an NC analog, 1,3-dimethyl-2-cyano-1-nitrosoguanidine (CyanoDMNG) in an NADPH-dependent reaction. The denitrosated guanidinium compound generated accounts for 50-70% of the nitroso compound metabolized in a microsomal incubate; nitrite is generated with a yield which represents 40-60% of the guanidinium compound produced. The cytochrome P450 inhibitors metyrapone, n-octylamine, 1-n-hexylimidazole and ellipticine inhibit the conversion of CyanoDMNG to 1,3-dimethyl-2-cyanoguanidine (Cyano-DMG) and nitrite. Microsomal NADPH-cytochrome c reductase activity is not perturbed by this series of organic compound inhibitors. Diethyl maleate at high concentrations weakly stimulates the reaction. The rates of production of the CyanoDMNG degradation products CyanoDMG, nitrite and nitrate are markedly diminished in nitrogen-saturated and in carbon dioxide-saturated microsomal incubates. Preincubating microsomes for 1 h at 37 degrees C prior to substrate and NADPH addition has no effect on the denitrosation activity. Kinetic analysis of the conversion of CyanoDMNG to CyanoDMG indicates a Km of 1.0 mM and a Vmax of 2.7 nmol/min/mg protein. Microsomes isolated from rats pretreated with the cytochrome P450 inducers pyrazole or phenobarbital show enhanced denitrosation activity. The denitrosation capacity of hamster liver microsomes is similar to that observed for rat microsomes.

摘要

1-甲基-2-硝基-1-亚硝基胍(MNNG)和亚硝基西咪替丁(NC)在啮齿动物体内的主要代谢途径是脱亚硝化作用,生成未修饰的母体胍化合物。MNNG是一种强效的局部作用致癌物。NC是西咪替丁的亚硝化衍生物,西咪替丁是一种口服用于治疗胃溃疡的重要临床药物。与基于各种短期体外致癌潜力测试结果的预期相反,给大鼠或小鼠施用NC时它不是致癌物。已发现大鼠肝微粒体酶能够在依赖NADPH的反应中催化MNNG、NC和一种NC类似物1,3-二甲基-2-氰基-1-亚硝基胍(氰基二甲硝咪唑,CyanoDMNG)的脱亚硝化作用。生成的脱亚硝化胍化合物占微粒体孵育物中代谢的亚硝基化合物的50 - 70%;亚硝酸盐的生成量占所产生胍化合物的40 - 60%。细胞色素P450抑制剂美替拉酮、正辛胺、1-正己基咪唑和玫瑰树碱抑制氰基二甲硝咪唑向1,3-二甲基-2-氰基胍(氰基-DMG)和亚硝酸盐的转化。微粒体NADPH-细胞色素c还原酶活性不受这一系列有机化合物抑制剂的干扰。高浓度的马来酸二乙酯对该反应有微弱的刺激作用。在氮气饱和和二氧化碳饱和的微粒体孵育物中,氰基二甲硝咪唑降解产物氰基-DMG、亚硝酸盐和硝酸盐的生成速率显著降低。在添加底物和NADPH之前,将微粒体在37℃预孵育1小时对脱亚硝化活性没有影响。氰基二甲硝咪唑向氰基-DMG转化的动力学分析表明,Km为1.0 mM(毫摩尔),Vmax为2.7纳摩尔/分钟/毫克蛋白质。从用细胞色素P450诱导剂吡唑或苯巴比妥预处理的大鼠中分离出的微粒体显示出增强的脱亚硝化活性。仓鼠肝微粒体的脱亚硝化能力与大鼠微粒体的相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验